DexCom isn't the only diabetes-focused company working on child-friendly devices. Its pediatric CGM could be peanut butter to Novo Nordisk's jelly. The Danish drugmaker ($NVO) is set to hit the U.S. market in early 2014 with its NovoPen Echo, a child-friendly insulin pen approved last August.